Ignite Creation Date:
2024-05-06 @ 6:49 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05795296
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-30
First Post:
2023-03-21
Brief Title:
Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer
Sponsor:
Organization:
RenJi Hospital